Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)

Bibliographic Details
Main Authors: Mooranian, A., Negrulj, R., Al-Sallami, H., Fang, Z., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Arfuso, Frank, Al-Salami, S.
Format: Journal Article
Published: Informa Healthcare 2015
Online Access:http://hdl.handle.net/20.500.11937/58456
_version_ 1848760265157378048
author Mooranian, A.
Negrulj, R.
Al-Sallami, H.
Fang, Z.
Mikov, M.
Golocorbin-Kon, S.
Fakhoury, M.
Arfuso, Frank
Al-Salami, S.
author_facet Mooranian, A.
Negrulj, R.
Al-Sallami, H.
Fang, Z.
Mikov, M.
Golocorbin-Kon, S.
Fakhoury, M.
Arfuso, Frank
Al-Salami, S.
author_sort Mooranian, A.
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T10:13:02Z
format Journal Article
id curtin-20.500.11937-58456
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:13:02Z
publishDate 2015
publisher Informa Healthcare
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-584562018-12-14T00:58:22Z Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014) Mooranian, A. Negrulj, R. Al-Sallami, H. Fang, Z. Mikov, M. Golocorbin-Kon, S. Fakhoury, M. Arfuso, Frank Al-Salami, S. 2015 Journal Article http://hdl.handle.net/20.500.11937/58456 10.3109/02652048.2015.1084094 Informa Healthcare unknown
spellingShingle Mooranian, A.
Negrulj, R.
Al-Sallami, H.
Fang, Z.
Mikov, M.
Golocorbin-Kon, S.
Fakhoury, M.
Arfuso, Frank
Al-Salami, S.
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title_full Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title_fullStr Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title_full_unstemmed Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title_short Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
title_sort release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
url http://hdl.handle.net/20.500.11937/58456